Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Irritable Bowel Syndrome (IBS) based on a standard set of medical criteria (called ROME III), with no other clear medical reason found for their symptoms (Group 1)
- People who have been diagnosed with active ulcerative colitis, confirmed by at least one internal bowel examination (Group 2)
- People who have ulcerative colitis that is currently in remission (not actively flaring), confirmed by at least one internal bowel examination — either with or without IBS symptoms (Group 3)
- Healthy volunteers who have no stomach or abdominal pain or complaints (Group 4)
- People who have been diagnosed with active Crohn's disease, confirmed by at least one internal bowel examination (Group 5)
- People who have Crohn's disease that is currently in remission (not actively flaring), confirmed by at least one internal bowel examination — either with or without IBS symptoms (Group 6)
- Participants in all groups must be willing to stop any medications that affect gut movement or sensation for at least 24 hours before the study
Who may not be able to join:
- People who have serious kidney disease, liver disease, thyroid problems, or problems with blood clotting
- People who have had abdominal surgery, unless it was a straightforward, uncomplicated appendix removal
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guy Boeckxstaens, MD, Catholic University Leuven and Universitary Hospitals Leuven
Phone: 0032-16-341943
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
differences in visceral sensitivity in different study groups (Visceral sensitivity will me measured by performing a rectal barostat test)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.